Solid‐Phase Parallel Synthesis of Photocleavable Bifunctional Molecules Enables Efficient Phenotypic Protein Degrader Discovery

B Baoli Ding (Institute of Pharmacology & Toxicology, Zhejiang Province Key Laboratory of Anti‐Cancer Drug Research College of Pharmaceutical Sciences Zhejiang University Hangzhou 310058 P.R. China) J Jiawen Hu R Rongtian Zhang (Institute of Pharmacology & Toxicology, Zhejiang Province Key Laboratory of Anti‐Cancer Drug Research College of Pharmaceutical Sciences Zhejiang University Hangzhou 310058 P.R. China) B Binyan Shou (Institute of Pharmacology & Toxicology, Zhejiang Province Key Laboratory of Anti‐Cancer Drug Research College of Pharmaceutical Sciences Zhejiang University Hangzhou 310058 P.R. China) M Mengdie Chen (Institute of Pharmacology & Toxicology, Zhejiang Province Key Laboratory of Anti‐Cancer Drug Research College of Pharmaceutical Sciences Zhejiang University Hangzhou 310058 P.R. China) L Li Jiang (Department of Radiation Oncology The First Affiliated Hospital of Guangxi Medical University Nanning China) M Meng Yuan B Bo Yang Q Qiaojun He J Ji Cao C Cheng‐Liang Zhu (Institute of Pharmacology & Toxicology, Zhejiang Province Key Laboratory of Anti‐Cancer Drug Research College of Pharmaceutical Sciences Zhejiang University Hangzhou 310058 P.R. China)

Abstract

Abstract Phenotypic screening offers an effective path for discovering protein degraders, particularly targeting proteins that are poorly characterized or lack sufficient ligand‐binding information. Nonetheless, phenotypic protein degrader discovery (PPDD) faces practical hurdles, such as synthetic complexity in generating chemically diverse libraries and difficulties in reliably identifying degradation‐driven phenotypes in direct‐to‐biology (D2B) assays. In response to these challenges, we developed an integrated PPDD platform that combines optimized solid‐phase parallel synthesis with a robust D2B screening workflow. Leveraging photocleavable linkers and versatile synthetic strategies, this platform facilitates rapid generation of chemically diverse, ready‐to‐screen bifunctional molecule libraries requiring minimal purification. As a proof of concept, we synthesized and phenotypically screened 130 cereblon‐recruiting molecules, leading to several promising protein degradation‐dependent hits. Subsequent hit optimization and target identification validated compound 12–60 as a structurally novel GSPT1 degrader with compelling cellular activity. Overall, our integrated platform represents an efficient and practical toolkit for PPDD, establishing a versatile foundation to accelerate future campaigns and expand the degradable proteome.

Article Details

Volume / Issue Vol. 64, Issue 31
Published July 28, 2025
ISSN 1433-7851
Publisher Wiley

Journal Info

Angewandte Chemie International Edition

Wiley

ISSN: 1433-7851 Physical Sciences

Authors (11)

B

Baoli Ding

Institute of Pharmacology & Toxicology, Zhejiang Province Key Laboratory of Anti‐Cancer Drug Research College of Pharmaceutical Sciences Zhejiang University Hangzhou 310058 P.R. China

J

Jiawen Hu

R

Rongtian Zhang

Institute of Pharmacology & Toxicology, Zhejiang Province Key Laboratory of Anti‐Cancer Drug Research College of Pharmaceutical Sciences Zhejiang University Hangzhou 310058 P.R. China

B

Binyan Shou

Institute of Pharmacology & Toxicology, Zhejiang Province Key Laboratory of Anti‐Cancer Drug Research College of Pharmaceutical Sciences Zhejiang University Hangzhou 310058 P.R. China

M

Mengdie Chen

Institute of Pharmacology & Toxicology, Zhejiang Province Key Laboratory of Anti‐Cancer Drug Research College of Pharmaceutical Sciences Zhejiang University Hangzhou 310058 P.R. China

L

Li Jiang

Department of Radiation Oncology The First Affiliated Hospital of Guangxi Medical University Nanning China

M

Meng Yuan

B

Bo Yang

Q

Qiaojun He

J

Ji Cao

C

Cheng‐Liang Zhu

Institute of Pharmacology & Toxicology, Zhejiang Province Key Laboratory of Anti‐Cancer Drug Research College of Pharmaceutical Sciences Zhejiang University Hangzhou 310058 P.R. China